Live Oak Private Wealth LLC Acquires 4,266 Shares of Danaher Co. (NYSE:DHR)

Live Oak Private Wealth LLC boosted its holdings in shares of Danaher Co. (NYSE:DHR - Free Report) by 12.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,407 shares of the conglomerate's stock after acquiring an additional 4,266 shares during the quarter. Danaher accounts for about 1.7% of Live Oak Private Wealth LLC's portfolio, making the stock its 18th largest position. Live Oak Private Wealth LLC's holdings in Danaher were worth $8,885,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of the business. Fairfield Bush & CO. lifted its position in shares of Danaher by 10.9% in the 1st quarter. Fairfield Bush & CO. now owns 4,840 shares of the conglomerate's stock worth $1,420,000 after purchasing an additional 475 shares during the period. Zions Bancorporation N.A. grew its stake in Danaher by 19.3% during the first quarter. Zions Bancorporation N.A. now owns 2,468 shares of the conglomerate's stock worth $724,000 after purchasing an additional 400 shares during the period. Covestor Ltd lifted its stake in Danaher by 76.8% in the first quarter. Covestor Ltd now owns 495 shares of the conglomerate's stock valued at $145,000 after buying an additional 215 shares during the period. NewEdge Advisors LLC grew its position in shares of Danaher by 14.1% during the 1st quarter. NewEdge Advisors LLC now owns 31,530 shares of the conglomerate's stock worth $9,248,000 after buying an additional 3,897 shares during the period. Finally, Bridgewater Associates LP increased its stake in shares of Danaher by 135.9% in the 1st quarter. Bridgewater Associates LP now owns 35,270 shares of the conglomerate's stock valued at $10,346,000 after acquiring an additional 20,320 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.

Insider Buying and Selling at Danaher

In other Danaher news, Director Teri List sold 3,289 shares of Danaher stock in a transaction dated Tuesday, February 6th. The stock was sold at an average price of $248.32, for a total transaction of $816,724.48. Following the completion of the transaction, the director now owns 19,726 shares of the company's stock, valued at approximately $4,898,360.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Danaher news, Director Teri List sold 3,289 shares of the stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $248.32, for a total value of $816,724.48. Following the sale, the director now directly owns 19,726 shares in the company, valued at approximately $4,898,360.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Daniel Raskas sold 23,757 shares of the business's stock in a transaction dated Monday, February 26th. The stock was sold at an average price of $252.00, for a total value of $5,986,764.00. Following the transaction, the senior vice president now owns 38,102 shares of the company's stock, valued at $9,601,704. The disclosure for this sale can be found here. Insiders have sold 32,957 shares of company stock valued at $8,265,802 in the last 90 days. 11.10% of the stock is currently owned by company insiders.

Danaher Stock Performance

Danaher stock traded down $3.99 during trading on Friday, hitting $240.02. The stock had a trading volume of 2,684,792 shares, compared to its average volume of 2,693,080. The company has a quick ratio of 1.37, a current ratio of 1.68 and a debt-to-equity ratio of 0.31. The stock has a market cap of $177.74 billion, a price-to-earnings ratio of 37.56, a price-to-earnings-growth ratio of 3.74 and a beta of 0.83. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $259.00. The stock's 50 day moving average is $249.71 and its two-hundred day moving average is $230.14.

Danaher (NYSE:DHR - Get Free Report) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $2.09 EPS for the quarter, beating the consensus estimate of $1.91 by $0.18. The business had revenue of $6.41 billion for the quarter, compared to the consensus estimate of $6.10 billion. Danaher had a net margin of 17.26% and a return on equity of 12.25%. The company's revenue was down 10.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.87 earnings per share. As a group, analysts predict that Danaher Co. will post 7.62 EPS for the current year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Thursday, March 28th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. This is a positive change from Danaher's previous quarterly dividend of $0.24. The ex-dividend date of this dividend is Wednesday, March 27th. Danaher's payout ratio is currently 16.90%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on DHR shares. KeyCorp raised their price objective on Danaher from $260.00 to $290.00 and gave the company an "overweight" rating in a research note on Thursday, February 1st. JPMorgan Chase & Co. upped their target price on shares of Danaher from $250.00 to $270.00 and gave the stock an "overweight" rating in a report on Wednesday, December 20th. Citigroup lifted their price target on Danaher from $255.00 to $280.00 and gave the company a "buy" rating in a research note on Wednesday, January 31st. Royal Bank of Canada upped their price target on Danaher from $254.00 to $282.00 and gave the stock an "outperform" rating in a report on Wednesday, January 31st. Finally, Raymond James lifted their price objective on shares of Danaher from $240.00 to $270.00 and gave the stock an "outperform" rating in a report on Wednesday, January 31st. Seven equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. According to data from MarketBeat.com, Danaher presently has an average rating of "Moderate Buy" and a consensus target price of $267.43.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.